INTRODUCTION {#sec1-1}
============

Sjögren-Larsson syndrome (SLS) is an autosomal recessive neurocutaneous disorder characterized by clinical triad of congenital ichthyosis, diplegia or tetraplegia, and learning disability/mental retardation.\[[@ref1]\] SLS is caused by mutation in the gene for fatty aldehyde dehydrogenase (FALDH) which catalyzes oxidation of long chain aliphatic alcohols to corresponding fatty acids. This leads to accumulation of aldehyde-modified lipids or fatty alcohol which probably disrupts the barrier function of skin and white matter of brain.\[[@ref2]\] We describe a series of six children with SLS seen over a period of 1 year to highlight their varied clinical presentation.

CASE REPORT {#sec1-2}
===========

The study comprised six children, ranging from 1 to 12 years with an equal gender ratio diagnosed as SLS seen during the period January 2012 to December 2012, referred from pediatric neurology department. The clinical summary of patients is described in [Table 1](#T1){ref-type="table"}. Four children were born of consanguineous marriage. Five children were born prematurely. History of collodion membrane was present in one child. All the children had ichthyosis since birth and were associated with delayed milestones and speech abnormalities \[[Table 1](#T1){ref-type="table"}\]. There was generalized ichthyosis in all patients with relative sparing of face \[[Figure 1](#F1){ref-type="fig"}\]. Type of scales varied from fine \[Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}\] to lamellar type \[Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}\]. Pruritus was present only in two children. Five children had seizures and were on anticonvulsants. Spastic diplegia was present in four cases and two children had spastic quadriplegia \[[Figure 6](#F6){ref-type="fig"}\]. One child (case 1) had cardiomegaly with congenital heart disease. One child had nystagmus. None of our children had any other ocular findings. Skin biopsy was done in all children; features showed hyperkeratosis, parakeratosis, and normal to thinned out granular layer with mild perivascular lymphocytic infiltrate in dermis consistent with ichthyosis \[[Figure 7](#F7){ref-type="fig"}\]. Brain magnetic resonance imaging (MRI) in all children revealed delayed myelination with signal changes in periventricular region predominantly involving occipital region \[[Figure 8](#F8){ref-type="fig"}\].

###### 

Clinical summary of patients

![](IDOJ-5-185-g001)

![Case 1-Fine scaling over extremities with sparing of face in a 1.5-year-old female child](IDOJ-5-185-g002){#F1}

![Case 2-X-linked type of ichthyosis over extremities](IDOJ-5-185-g003){#F2}

![Case 3-Fine scaling over extremities similar to ichthyosis vulgaris](IDOJ-5-185-g004){#F3}

![Case 4-Three-year-old male child with lamellar type of scales over the extremities](IDOJ-5-185-g005){#F4}

![Case 5-Lamellar type of scaling over extremities](IDOJ-5-185-g006){#F5}

![Case 6-Generalized ichthyosis (lamellar type scales) with spastic quadriplegia](IDOJ-5-185-g007){#F6}

![Epidermis shows hyperkeratosis, parakeratosis, thinned out granular layer with mild perivascular lymphocytic infiltrate in dermis (H and E, ×40)](IDOJ-5-185-g008){#F7}

![T2-weighted magnetic resonance imaging (MRI) showing signal changes in bilateral peritrigonal regions](IDOJ-5-185-g009){#F8}

DISCUSSION {#sec1-3}
==========

In 1957, Sjögren and Larsson described the disorder affecting 28 patients from a highly consanguineous population in a remote area of Sweden with clinical triad of mental retardation, spastic diplegia, and congenital ichthyosis.\[[@ref1]\] The incidence of SLS is 1 in 200,000 births in Sweden, but it occurs more rarely worldwide. SLS is caused due to recessive mutations in the fatty aldehyde dehydrogenase (FALDH) gene FALDH3A2 on the short arm of chromosome 17p11.\[[@ref2]\] More than 72 mutations in FALDH3A2 are known in SLS patients.\[[@ref3]\]

The disorder presents at birth or in the neonatal period with varying degrees of erythema and ichthyosis, but a collodion membrane is rarely seen. Infants with SLS tend to be born prematurely. Although erythema may be present at birth, it is usually not evident after a year of age. Persistent pruritus is common. The morphology of the scaling may be fine, dandruff-like similar to ichthyosis vulgaris or X-linked recessive ichthyosis or lamellar similar to autosomal recessive congenital ichthyosis.\[[@ref4]\] The ichthyosis is generalized, but sites more predominantly affected are lower abdomen, sides and nape of neck, and flexures. A distinctive sign is periumbilical hyperkeratosis with radiating furrows.\[[@ref5]\] Palmoplantar keratoderma is seen in 50% of cases. The diagnosis of SLS is delayed until the onset of neurological symptoms, because only cutaneous manifestations are present at birth.

The neurological symptoms appear in the first or second year of life. Speech and motor delays are the common initial signs. Spasticity appears before 3 years of age and is more severe in lower limbs. Seizures are present in one-third of patients. There is no progression of neurological findings or mental retardation after puberty.\[[@ref6]\] Neuroimaging studies of the cerebral white matter and corticospinal tracts shows white matter disease, delayed myelination, periventricular gliosis, and a permanent myelin deficit.\[[@ref7]\] One-third of patients present with perifoveal glistening dots in the ocular fundus which appear after several years of age.\[[@ref8]\] None of the children in our cohort had retinal changes. Long-term follow-up is necessary to document retinal changes.

The histopathological features are nonspecific and include hyperkeratosis and acanthosis with a normal granular layer. The diagnosis of SLS can be confirmed by measurement of enzyme activity in cultured skin fibroblasts or leucocytes. Sequence analysis of FALDH3A2 gene causing mutations is highly sensitive and also detects possible carrier.\[[@ref9]\]

There is no permanent cure for SLS and no specific therapy. Multidisciplinary approach includes team of dermatologist, neurologist, ophthalmologist, orthopaedician, and physiotherapist. Topical emollients, keratolytics, calcipotriol, and oral retinoids can be used to improve the cutaneous symptoms.\[[@ref10]\] All our patients were managed symptomatically with topical emollients and keratolytics. Cutaneous symptoms improved after treatment.

In our case series, one child had congenital heart disease and cardiomegaly that has not been described in earlier reports. Due to the limited availability of diagnostic laboratories, enzyme analysis was not done in our study. High index of suspicion is necessary for the diagnosis of SLS. Any case of congenital ichthyosis with spastic paresis and mental retardation should be evaluated for SLS.
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